Elevated antiviral, myeloid and endothelial inflammatory markers in severe COVID-19 (2020)
Attributed to:
ISARIC - Coronavirus Clinical Characterisation Consortium (ISARIC-4C)
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.10.08.20209411
Publication URI: http://dx.doi.org/10.1101/2020.10.08.20209411
Type: Preprint